查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2077813

2026年全球抗藥性金黃色葡萄球菌（MRSA）檢測市場報告

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，抗藥性金黃色葡萄球菌（MRSA）檢測市場發展迅速。預計該市場將從2025年的39.5億美元成長到2026年的41.8億美元，年複合成長率（CAGR）為5.8%。過去幾年成長要素包括醫院感染病例的增加、人們對抗生素抗藥性的認知不斷提高、診斷檢測基礎設施的擴充、醫院感染控制項目的擴展以及基於培養的診斷方法的廣泛應用。

預計未來幾年抗藥性金黃色葡萄球菌(MRSA) 檢測市場將保持強勁成長，到 2030 年將達到 52.8 億美元，複合年成長率 (CAGR) 為 6.0%。預測期內的成長主要受以下因素驅動：快速分子診斷技術的日益普及、精準醫療和病原體基因組學投資的增加、自動化檢測系統的擴展、對即時感染監測需求的成長以及監管機構對抗菌素抗藥性的日益重視。預測期內的關鍵趨勢包括：用於抗菌素抗藥性檢測的快速分子診斷技術應用日益廣泛、醫院中即時 (PoC) MRSA 檢測的使用增加、診斷檢查室中自動化微生物工作流程的擴展、醫療機構感染監測項目的加強以及對院內感染篩檢的多種檢測方法的需求增加。

院內感染（HAI）的日益普遍預計將推動抗藥性金黃色葡萄球菌（MRSA）檢測市場的成長。 HAI是指患者在醫療機構接受內科或外科手術時發生的繼發性感染。受醫療程序日益複雜化和免疫力缺乏患者數量不斷增加等因素的影響，全球HAI發生率正在上升。這為機會性病原體定植提供了更多機會。 MRSA檢測有助於控制這些感染疾病，使臨床醫生能夠及早識別定植患者並實施隔離方案，從而防止感染在醫療機構內傳播。例如，根據英國衛生安全局的數據，2025年8月報告的MRSA菌血症病例總數達到81例，比2024年8月的75例增加了8.0%。因此，HAI的日益普遍正在推動和支持MRSA檢測市場的成長。

在抗藥性金黃色葡萄球菌(MRSA) 檢測市場中，領導企業正致力於將人工智慧 (AI) 整合到其檢測方法中，包括 AI 影像分析，以獲得競爭優勢。 AI 影像分析利用人工智慧演算法，在 MRSA篩檢流程中自動且準確地分析顯色瓊脂平板上的細菌生長模式。例如，2023 年 5 月，美國醫療技術公司貝克頓·迪金森公司 (BD) 的「BD Kiestra MRSA Imaging」應用程式獲得了 FDA 510(k) 批准。此應用可自動偵測培養皿中淡紫色 MRSA 菌落，實現批量陰性結果的確認，並與 BD Synapsys Informatics 系統協同工作，高效管理工作清單。這為檢查室帶來許多好處，例如縮短檢測結果報告時間、減輕工作量，以及將人員重新分配到更複雜的分析任務。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球抗藥性金黃色葡萄球菌(MRSA) 檢測市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧和自主智慧
    • 工業4.0和智慧製造
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 快速分子診斷方法在檢測抗生素抗藥性方面正變得越來越普及。
    • 擴大醫院即時MRSA檢測的使用
    • 擴大診斷檢查室中自動化微生物工作流程的應用
    • 擴大醫療機構感染監測計劃
    • 對用於院內感染篩檢。

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷檢查室
  • 研究機構
  • 門診部
  • 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球抗藥性金黃色葡萄球菌(MRSA) 檢測市場：PESTEL 分析
  • 全球抗藥性金黃色葡萄球菌(MRSA) 檢測市場：規模、對比及成長率分析
  • 全球抗藥性金黃色葡萄球菌(MRSA) 檢測市場表現：規模與成長，2020-2025 年
  • 全球抗藥性金黃色葡萄球菌(MRSA) 檢測市場預測：規模與成長，2025-2030 年，2035 年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按類型
  • 醫療機構相關抗藥性金黃色葡萄球菌、社區型抗藥性金黃色葡萄球菌、院內獲得性抗藥性金黃色葡萄球菌
  • 適應症
  • 皮膚和軟組織感染疾病（SSTI）、肺炎、血液感染疾病、外科和內科感染疾病以及其他適應症。
  • 透過技術
  • 聚合酵素鏈鎖反應（PCR）、即時聚合酵素鏈鎖反應（RT-PCR）、顯色培養基、酵素免疫分析法（ELISA）及其他技術
  • 最終用戶
  • 醫院、診斷檢測實驗室、研究機構、門診部和其他最終用戶
  • 細分（按類型）：醫療機構相關抗藥性金黃色葡萄球菌
  • 加護病房相關感染疾病、導管相關感染疾病、人工呼吸器相關感染疾病、術後傷口感染疾病及長期照護機構感染疾病。
  • 按類型細分：社區抗藥性金黃色葡萄球菌
  • 皮膚和軟組織感染疾病、運動相關感染疾病、家庭感染、社區爆發、學校和托兒所相關感染疾病
  • 細分（按類型）：醫院獲得抗藥性金黃色葡萄球菌
  • 手術部位感染、血液感染、呼吸道感染疾病、醫療設備相關感染、傷口及燒傷感染疾病

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 抗藥性金黃色葡萄球菌（MRSA）檢測市場：競爭格局與市場佔有率，2024年
  • 抗藥性金黃色葡萄球菌(MRSA) 檢測市場：公司估值矩陣
  • 抗藥性金黃色葡萄球菌（MRSA）檢測市場：公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Becton Dickinson and Company

第37章 其他大型企業和創新企業

  • bioMerieux SA, Hologic Inc., QuidelOrtho Corporation, Bruker Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Randox Laboratories Ltd., SD Biosensor Inc., Seegene Inc., Hardy Diagnostics Inc., Alifax Srl, Ganesh Diagnostic and Imaging Centre Pvt. Ltd., Uniogen Oy, 3B BlackBio Dx Limited, Orange Health Labs Private Limited

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年抗藥性金黃色葡萄球菌（MRSA）檢測市場：提供新機會的國家
  • 2030年抗藥性金黃色葡萄球菌（MRSA）檢測市場：提供新機會的細分市場
  • 抗藥性金黃色葡萄球菌(MRSA) 檢測市場，2030 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: EE3MMUPT01_G26Q2

Methicillin-resistant Staphylococcus aureus (MRSA) testing refers to a range of diagnostic procedures used to identify the presence of methicillin-resistant Staphylococcus aureus bacteria in clinical specimens in order to support infection control and treatment decisions. These testing techniques typically include molecular diagnostic methods, culture-based approaches, and immunoassays to ensure accurate and timely detection of resistant strains. They are commonly applied in hospitals, diagnostic laboratories, and outpatient settings to help prevent the spread of infections and guide appropriate antibiotic therapy.

The primary types of methicillin-resistant staphylococcus aureus (MRSA) testing include healthcare acquired methicillin resistant staphylococcus aureus, community acquired methicillin resistant staphylococcus aureus, and hospital acquired methicillin resistant staphylococcus aureus. Healthcare acquired methicillin resistant staphylococcus aureus refers to infections identified in patients exposed to healthcare settings such as hospitals or long-term care facilities. These tests are applied across indications such as skin and soft tissue infections (SSTIS), pneumonia, bloodstream infections, surgical and medical infections, and other indications. The various technologies involved are polymerase chain reaction (PCR), real time polymerase chain reaction (RT-PCR), chromogenic media, enzyme linked immunosorbent assay (ELISA), and other technologies, and they are used by several end users such as hospitals, diagnostic laboratories, research institutes, ambulatory care centers, and other end users.

Tariffs are influencing the Methicillin-resistant staphylococcus aureus (MRSA) testing market by driving up the cost of imported diagnostic reagents, molecular testing kits, and laboratory instruments essential for the accurate detection of resistant infections. This is impacting healthcare providers and diagnostic laboratories by increasing operational expenses and delaying the adoption of advanced PCR, ELISA, and rapid testing technologies, especially in import-dependent regions such as Asia-Pacific and Latin America. Hospitals, diagnostic laboratories, and ambulatory care centers are experiencing the greatest impact due to their dependence on global supply chains for critical testing components. However, tariffs are also promoting local production of diagnostic kits, diversification of regional supply chains, and greater investment in domestic biotechnology capabilities, ultimately enhancing long-term diagnostic resilience and self-sufficiency.

The methicillin-resistant staphylococcus aureus (MRSA) testing market research report is one of a series of new reports from The Business Research Company that provides methicillin-resistant staphylococcus aureus (MRSA) testing market statistics, including methicillin-resistant staphylococcus aureus (MRSA) testing industry global market size, regional shares, competitors with a methicillin-resistant staphylococcus aureus (MRSA) testing market share, detailed methicillin-resistant staphylococcus aureus (MRSA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the methicillin-resistant staphylococcus aureus (MRSA) testing industry. This methicillin-resistant staphylococcus aureus (MRSA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The methicillin-resistant staphylococcus aureus (MRSA) testing market size has grown strongly in recent years. It will grow from $3.95 billion in 2025 to $4.18 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rising prevalence of hospital-acquired infections, increasing awareness of antibiotic resistance, expansion of diagnostic laboratory infrastructure, growth in hospital infection control programs, increasing use of culture-based diagnostic methods.

The methicillin-resistant staphylococcus aureus (MRSA) testing market size is expected to see strong growth in the next few years. It will grow to $5.28 billion by 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rising adoption of rapid molecular diagnostic technologies, increasing investment in precision medicine and pathogen genomics, expansion of automated laboratory systems, growing demand for real-time infection surveillance, stricter regulatory focus on antimicrobial resistance control. Major trends in the forecast period include rising adoption of rapid molecular diagnostics for antibiotic resistance detection, increasing use of point-of-care MRSA testing in hospitals, growing implementation of automated microbiology workflows in diagnostic laboratories, expansion of infection surveillance programs in healthcare facilities, increasing demand for multiplex assays for hospital-acquired infection screening.

The increasing prevalence of hospital-acquired infections is expected to propel the growth of the methicillin-resistant Staphylococcus aureus (MRSA) testing market going forward. Hospital-acquired infections (HAIs) are secondary infections that patients contract while receiving medical or surgical treatment within a healthcare facility. This prevalence is rising globally, contributing to the increasing complexity of medical procedures and the growing number of immunocompromised patients, which create greater opportunities for opportunistic pathogens to colonize. MRSA testing supports the management of these infections by enabling clinicians to identify colonized patients at an early stage and implement isolation protocols to prevent facility-wide transmission. For instance, in August 2025, according to the Health Security Agency, a UK-based national executive agency, the overall reported MRSA bacteremia cases reached 81, representing an 8.0% increase compared to 75 cases in August 2024. Therefore, the increasing prevalence of hospital-acquired infections is propelling and supporting the growth of the MRSA testing market.

Leading companies operating in the methicillin-resistant Staphylococcus aureus (MRSA) testing market are focusing on integrating artificial intelligence in testing, such as AI-powered imaging analysis, to gain a competitive advantage. AI-powered imaging analysis uses artificial intelligence algorithms to interpret bacterial growth patterns on chromogenic media plates automatically and accurately in MRSA screening workflows. For example, in May 2023, Becton, Dickinson and Company (BD), a US-based medical technology company, received FDA 510(k) clearance for the BD Kiestra MRSA Imaging application. This application automates Petri dish inspection for mauve-colored MRSA colonies, enables batch review of negative results, and integrates with BD Synapsys Informatics for efficient worklist organization. Laboratories benefit from reduced turnaround times, minimized labor burdens, and reallocation of staff to complex analyses.

In May 2024, Bruker Corporation, a US-based provider of in-vitro diagnostics, molecular diagnostics, and clinical testing solutions, acquired the molecular diagnostics division of ELITechGroup for an undisclosed value. Through this acquisition, Bruker seeks to enhance its molecular diagnostics capabilities by integrating PCR-based infectious disease testing platforms that enable detection of infectious diseases, including hospital-acquired infections such as Methicillin-resistant Staphylococcus aureus (MRSA), thereby strengthening its position in the molecular diagnostics and clinical microbiology sectors. ELITechGroup is a France-based provider of molecular diagnostic solutions that offers PCR-based testing systems for infectious disease detection and clinical microbiology applications in hospital and laboratory environments.

Major companies operating in the methicillin-resistant staphylococcus aureus (mrsa) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMerieux SA, Hologic Inc., QuidelOrtho Corporation, Bruker Corporation, Bio-Rad Laboratories Inc., QIAGEN N. V., Randox Laboratories Ltd., SD Biosensor Inc., Seegene Inc., Hardy Diagnostics Inc., Alifax S. r. l., Ganesh Diagnostic and Imaging Centre Pvt. Ltd., Uniogen Oy, 3B BlackBio Dx Limited, Orange Health Labs Private Limited

North America was the largest region in the methicillin-resistant staphylococcus aureus (MRSA) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the methicillin-resistant staphylococcus aureus (MRSA) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the methicillin-resistant staphylococcus aureus (MRSA) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The methicillin-resistant staphylococcus aureus (MRSA) testing market consists of revenues earned by entities by providing services such as hospital laboratory testing, diagnostic lab services, point-of-care testing services, and infection screening programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The methicillin-resistant staphylococcus aureus (MRSA) testing market also includes sales of PCR test kits, culture media and chromogenic agar plates, automated diagnostic instruments, reagents, assay kits, and control materials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses methicillin-resistant staphylococcus aureus (mrsa) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for methicillin-resistant staphylococcus aureus (mrsa) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The methicillin-resistant staphylococcus aureus (mrsa) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Healthcare Acquired Methicillin Resistant Staphylococcus Aureus; Community Acquired Methicillin Resistant Staphylococcus Aureus; Hospital Acquired Methicillin Resistant Staphylococcus Aureus
  • 2) By Indication: Skin And Soft Tissue Infections (SSTIs); Pneumonia; Bloodstream Infections; Surgical And Medical Infections; Other Indications
  • 3) By Technology: Polymerase Chain Reaction (PCR); Real Time Polymerase Chain Reaction (RT-PCR); Chromogenic Media; Enzyme Linked Immunosorbent Assay (ELISA); Other Technologies
  • 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Ambulatory Care Centers; Other End Users
  • Subsegments:
  • 1) By Healthcare Acquired Methicillin Resistant Staphylococcus Aureus: Intensive Care Unit Associated Infections; Catheter Related Infections; Ventilator Associated Infections; Post Surgical Site Infections; Long Term Care Facility Infections
  • 2) By Community Acquired Methicillin Resistant Staphylococcus Aureus: Skin And Soft Tissue Infections; Athlete Associated Infections; Household Transmission Infections; Community Cluster Infections; School And Daycare Associated Infections
  • 3) By Hospital Acquired Methicillin Resistant Staphylococcus Aureus: Surgical Site Infections; Bloodstream Infections; Respiratory Tract Infections; Device Associated Infections; Wound And Burn Infections
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company; bioMerieux SA; Hologic Inc.; QuidelOrtho Corporation; Bruker Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Randox Laboratories Ltd.; SD Biosensor Inc.; Seegene Inc.; Hardy Diagnostics Inc.; Alifax S.r.l.; Ganesh Diagnostic and Imaging Centre Pvt. Ltd.; Uniogen Oy; 3B BlackBio Dx Limited; Orange Health Labs Private Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things, Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Rapid Molecular Diagnostics For Antibiotic Resistance Detection
    • 4.2.2 Increasing Use Of Point-Of-Care MRSA Testing In Hospitals
    • 4.2.3 Growing Implementation Of Automated Microbiology Workflows In Diagnostic Laboratories
    • 4.2.4 Expansion Of Infection Surveillance Programs In Healthcare Facilities
    • 4.2.5 Increasing Demand For Multiplex Assays For Hospital-Acquired Infection Screening

5. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Ambulatory Care Centers
  • 5.5 Other End Users

6. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Segmentation

  • 9.1. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Healthcare Acquired Methicillin Resistant Staphylococcus Aureus, Community Acquired Methicillin Resistant Staphylococcus Aureus, Hospital Acquired Methicillin Resistant Staphylococcus Aureus
  • 9.2. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Skin And Soft Tissue Infections (SSTIs), Pneumonia, Bloodstream Infections, Surgical And Medical Infections, Other Indications
  • 9.3. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Real Time Polymerase Chain Reaction (RT-PCR), Chromogenic Media, Enzyme Linked Immunosorbent Assay (ELISA), Other Technologies
  • 9.4. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Laboratories, Research Institutes, Ambulatory Care Centers, Other End Users
  • 9.5. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Sub-Segmentation Of Healthcare Acquired Methicillin Resistant Staphylococcus Aureus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Intensive Care Unit Associated Infections, Catheter Related Infections, Ventilator Associated Infections, Post Surgical Site Infections, Long Term Care Facility Infections
  • 9.6. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Sub-Segmentation Of Community Acquired Methicillin Resistant Staphylococcus Aureus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Skin And Soft Tissue Infections, Athlete Associated Infections, Household Transmission Infections, Community Cluster Infections, School And Daycare Associated Infections
  • 9.7. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Sub-Segmentation Of Hospital Acquired Methicillin Resistant Staphylococcus Aureus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Surgical Site Infections, Bloodstream Infections, Respiratory Tract Infections, Device Associated Infections, Wound And Burn Infections

10. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Regional And Country Analysis

  • 10.1. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 11.1. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 12.1. China Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 13.1. India Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 14.1. Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 15.1. Australia Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 16.1. Indonesia Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 17.1. South Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 18.1. Taiwan Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 19.1. South East Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 20.1. Western Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 21.1. UK Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 22.1. Germany Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 23.1. France Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 24.1. Italy Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 25.1. Spain Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 26.1. Eastern Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 27.1. Russia Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 28.1. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 29.1. USA Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 30.1. Canada Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 31.1. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 32.1. Brazil Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 33.1. Middle East Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

  • 34.1. Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market, Segmentation By Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Regulatory and Investment Landscape

36. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Competitive Landscape And Company Profiles

  • 36.1. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Other Major And Innovative Companies

  • bioMerieux SA, Hologic Inc., QuidelOrtho Corporation, Bruker Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Randox Laboratories Ltd., SD Biosensor Inc., Seegene Inc., Hardy Diagnostics Inc., Alifax S.r.l., Ganesh Diagnostic and Imaging Centre Pvt. Ltd., Uniogen Oy, 3B BlackBio Dx Limited, Orange Health Labs Private Limited

38. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

41. Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market High Potential Countries, Segments and Strategies

  • 41.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer